📢 New in #eGastroenterology: TERT rs10069690 shows contrasting links to cholangiocarcinoma.

🧬 Lower intrahepatic CCA risk
📉 Shorter survival after resection
🛡️ Links to immune and proliferation signatures

🔗 doi.org/10.1136/egas...

#Cholangiocarcinoma #TERT #CancerGenetics #LiverCancer

💜 Stay warm and show your support 💜

If you're out fundraising, walking the dog or just out and about, it’s a great way to keep warm, and can be a great conversation starter about #CCA and #AMMF too!

Buy yours here: https://ammf.org.uk/product/beanie-hat/
#bileductcancer #Cholangiocarcinoma

AMMF are advocating for the Cholangiocarcinoma patients and continuing our campaign to ‘Reth!nk Liver Cancer’ at the Big Cancer52 Conversation in London💜📢🙌

#AMMF #Cholangiocarcinoma # CCA #Bileductcancer

#Cholangiocarcinoma, or #bileductcancer, is a primary liver cancer which starts in the inside lining of the ducts of the biliary tree; this is a network of tubes that carry bile from the liver to the gut.

To find out more visit: https://ammf.org.uk/about-cholangiocarcinoma/

#rethinklivercancer

💜 🍂Feeling the autumn chill this October? 🍂💜

Help raise awareness of #cholangiocarcinoma wherever you go and order your AMMF hoodie here: https://ammf.org.uk/product/hoodie/

#bileductcancer #CCA

💜October is Liver Cancer Awareness Month 💜

#Cholangiocarcinoma is a primary liver cancer! Once considered rare, this is no longer the case.

It’s time to Reth!nk Liver Cancer.

We'll be raising awareness and sharing information about #CCA throughout the month.

#AMMF #bileductcancer #livercancer

We need more of this type of work looking at differences between primary lesion and intrahepatic metastases in understudied #cholangiocarcinoma for development of better #TME targeting treatments

www.ovid.com/10.1097/HEP....

📢 New Review in #LiversMDPI

🧬 Digital and biological twins in cholangiocarcinoma

🩺 Fully realized medical digital twins remain unavailable, while biological twins face scalability and standardization challenges.

📖 Read More: www.mdpi.com/2673-4389/6/...

#PrecisionOncology #Cholangiocarcinoma

📢 ICYMI: The #FDA has approved lirafugratinib (Lyrfigtu) for adults with previously treated unresectable, locally advanced or metastatic #cholangiocarcinoma harboring an FGFR2 gene fusion or other rearrangement.

Read more: targetedonc.com/view/fda-app...

#Oncology #CancerTreatment

FDA Approves #Lirafugratinib for Previously Treated #FGFR2-Altered #Cholangiocarcinoma: www.pharmacytimes.com/view/fda-app...

FDA News: REFOCUS Update in #Cholangiocarcinoma

On September 23, 2026, the FDA🇺🇸 approved lirafugratinib for adults with previously treated, unresectable, locally advanced or metastatic cholangiocarcinoma harboring FGFR2🧬 fusions or rearrangements.

www.fda.gov/drugs/resour...

Not sure what support is available to you? #AMMF has a host of helpful links available of external resources which are focused on helping anyone affected by #cholangiocarcinoma.

Remember, support is always available and AMMF are always here 💜

https://ammf.org.uk/helpful-links/

Precision medicine is transforming #cholangiocarcinoma care.
This review highlights advances in targeted therapies and #immunotherapy while addressing challenges such as drug resistance and biomarker discovery. #TumorMicroenvironment
#GenesAndDiseases: doi.org/10.1016/j.ge...

#AMMF Palliative Care Webinar

Where we will be dispelling the myths and understanding the facts of palliative care.

📅 Wednesday 23 September 2026
⏰ 6pm – 7:30pm
🔗 https://us02web.zoom.us/webinar/register/WN_aIqza-pVQMmA7dfSNouZAw

#Cholangiocarcinoma #CCA #BileDuctCancer

🔬AMMF Funded Research🔬

Head over to #AMMF’s Facebook to hear about Arezoo Ghodsifard’s research on ‘Artificial Intelligence as a Biomarker for Intrahepatic #Cholangiocarcinoma’.

#CCA #BileDuctCancer

🔬AMMF Funded Research🔬

Head over to #AMMF’s Facebook to hear about Professor Shijie Cai’s Research on ‘Unleashing the power of normal cholangiocytes to counteract #cholangiocarcinoma’.

#CCA #BileDuctCancer